|
Market Closed -
Nasdaq
00:00:00 15/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.650 USD | +57.96% |
|
+62.59% | -76.96% |
| 08-14 | Capricor shares soar as potential FDA lifeline revives Duchenne drug hopes | RE |
| 08-14 | Capricor Therapeutics Shares Surge 98% as FDA Agrees to Review Deramiocel Application Amendment | MT |
| Market Cap | 387M 334M 314M 285M 537M 36.97B 545M 3.68B 1.44B 18.51B 1.45B 1.42B 61.52B | P/E 2026 * |
-3.06x | P/E 2027 * | -4.14x |
|---|---|---|---|---|---|
| Enterprise Value | 387M 334M 314M 285M 537M 36.97B 545M 3.68B 1.44B 18.51B 1.45B 1.42B 61.52B | EV / Sales 2026 * |
24.4x | EV / Sales 2027 * | 8.94x |
| Free-Float |
90.22% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Capricor Therapeutics, Inc.
| 1 day | +57.96% | ||
| 1 week | +62.59% | ||
| Current month | +72.73% | ||
| 1 month | -67.32% | ||
| 3 months | -76.90% | ||
| 6 months | -70.38% | ||
| Current year | -76.96% |
| 1 week | 3.73 |  | 8.15 |
| 1 month | 2.96 | | 20.54 |
| Current year | 2.96 | | 36.82 |
| 1 year | 2.96 | | 40.37 |
| 3 years | 2.68 | | 40.37 |
| 5 years | 2.56 | | 40.37 |
| 10 years | 0.88 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 20/11/2013 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 01/01/2018 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 13/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Litvack
CHM | Chairman | 70 | 01/11/2013 |
David Musket
BRD | Director/Board Member | 68 | 20/11/2013 |
George Dunbar
BRD | Director/Board Member | 79 | 20/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/04/26 | Fiscal year | Director | 22,587 | 0.0393% | ||
| 05/01/26 | Free | General Counsel | 45,000 | 0.0827% | ||
| 05/01/26 | Free | Director | 15,500 | 0.0285% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +57.96% | +62.59% | -16.46% | -6.86% | 387M | |
| -1.90% | +2.85% | +62.82% | +104.13% | 70.07B | |
| -3.21% | -4.32% | +31.85% | +57.27% | 52.87B | |
| -2.05% | -5.61% | -3.18% | +449.71% | 27.02B | |
| -1.27% | -1.57% | +45.90% | +8.25% | 23.61B | |
| +1.05% | -0.62% | -18.00% | -11.93% | 23.38B | |
| +3.81% | +20.97% | +266.37% | +531.28% | 19.43B | |
| +0.10% | +1.40% | +35.36% | -19.94% | 18.75B | |
| -0.95% | -3.52% | +19.93% | +594.00% | 15.85B | |
| +1.24% | -5.23% | +33.75% | +137.66% | 12.7B | |
| Average | +5.48% | +8.01% | +45.83% | +184.36% | 26.41B | |
| Weighted average by Cap. | -1.00% | +0.65% | +50.14% | +164.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.82M 13.67M 12.84M 11.68M 21.96M 1.51B 22.32M 150M 58.83M 758M 59.4M 58.11M 2.52B | 43.24M 37.34M 35.09M 31.91M 60M 4.13B 60.99M 411M 161M 2.07B 162M 159M 6.88B |
| Net income | -126M -109M -102M -92.99M -175M -12.05B -178M -1.2B -468M -6.03B -473M -463M -20.05B | -96.36M -83.23M -78.21M -71.13M -134M -9.21B -136M -916M -358M -4.61B -362M -354M -15.33B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | $6.650 | +57.96% | 66,333,884 |
| 13/08/26 | $4.210 | +0.48% | 16,749,501 |
| 12/08/26 | $4.190 | +6.62% | 2,752,846 |
| 11/08/26 | $3.930 | +2.08% | 3,331,704 |
| 10/08/26 | $3.850 | -5.87% | 3,088,697 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAPR Stock
Select your edition
All financial news and data tailored to specific country editions
